Virsti Therapeutics
Stanford, US · Founded 2021 · Delaware corporation
Founders & leadership
AE
Allen Ebens, Ph.D.Executive
JC
Jennifer Cochran, Ph.D.Named on SEC filing
Board
HL
Heath Lukatch, Ph.D.Board director
JE
Jon Edwards, Ph.D.Board director
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 1 round · 2021
▶$1.4MraisedApr 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.4MraisedApr 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Heath Lukatch, Ph.D.Director
- Jennifer Cochran, Ph.D.Director
- Jon Edwards, Ph.D.Director
- Allen Ebens, Ph.D.Executive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.4M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Virsti Therapeutics raised?
- Virsti Therapeutics has disclosed $1.4M raised across 1 round.
- Where is Virsti Therapeutics headquartered?
- Virsti Therapeutics is headquartered in Stanford, US.